ReviewFrontiers in bioengineering and biotechnology2026
A noninvasive bioengineering technology for testing medical monitoring capabilities for conditions of human hypovolemia and hypotension.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of a Wearable Photoplethysmography-Based Sensor for Compensatory Reserve Measurement Monitoring in Simulated Human Hemorrhage.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testing new medical monitors and wearable sensors designed to assess patient status under conditions of hypovolemia and/or hypotension are necessary to improve clinical outcomes of individuals with hemorrhagic injuries. Lower body negative pressure (LBNP) has emerged as a bioengineering tool that can induce progressive reductions in central blood volume similar to those experienced by patients during the early stages of physiological compensation during blood loss. The objective of this review is to develop a working framework for biomedical engineering research involving a safe noninvasive human hypovolemia model for the systematic testing of medical monitoring sensors and devices. As a testing tool, this paper provides a summary of the safety and advantages of using LBNP to avoid the use of blood withdrawal approaches compared to actual controlled hemorrhage. In this regard, LBNP provides a safe and non-invasive technology for testing advanced medical monitoring technologies with the potential to improve emergency clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.